CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

NCT04913896 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Magnetic Resonance Imaging
Tomography, X-Ray Computed
Neoadjuvant Immunotherapy
Neoadjuvant Chemotherapy

Interventions

DRUG: PD-1 inhibitor

Sponsor

The First Hospital of Jilin University